The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management
Open accessAbstract
Diabetic nephropathy (DN) has been recognized as a severe complication of diabetes mellitus and a dominant pathogeny of end-stage kidney disease, which causes serious health problems and great financial burden to human society worldwide. Conventional strategies, such as renin-angiotensin-aldosterone system blockade, blood glucose level control, and bodyweight reduction, may not achieve satisfactory outcomes in many clinical practices for DN management. Notably, due to the multi-target function, Chinese medicine possesses promising clinical benefits as primary or alternative therapies for DN treatment. Increasing studies have emphasized identifying bioactive compounds and molecular mechanisms of reno-protective effects of Chinese medicines. Signaling pathways involved in glucose/lipid metabolism regulation, antioxidation, anti-inflammation, anti-fibrosis, and podocyte protection have been identified as crucial mechanisms of action. Herein, we summarize the clinical efficacies of Chinese medicines and their bioactive components in treating and managing DN after reviewing the results demonstrated in clinical trials, systematic reviews, and meta-analyses, with a thorough discussion on the relative underlying mechanisms and molecular targets reported in animal and cellular experiments. We aim to provide comprehensive insights into the protective effects of Chinese medicines against DN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thomas, M. C., Brownlee, M., Susztak, K., Sharma, K., Jandeleit-Dahm, K. A. M., Zoungas, S., Rossing, P., Groop, P.-H., & Cooper, M. E. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.18 · Cited by 1,230
Temporal trends in the prevalence of diabetic kidney disease in the United States
de Boer, I. H. (2011) · JAMA · doi:10.1001/jama.2011.861 · Cited by 1,036
CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease
Anders, H.-J., Huber, T. B., Isermann, B., & Schiffer, M. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0001-y · Cited by 796
Renal and retinal effects of enalapril and losartan in type 1 diabetes
Mauer, M., Zinman, B., Gardiner, R., Suissa, S., Sinaiko, A., Strand, T., Drummond, K., Donnelly, S., Goodyer, P., Gubler, M. C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808400 · Cited by 791
Epigenetics and epigenomics in diabetic kidney disease and metabolic memory
Kato, M., & Natarajan, R. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0135-6 · Cited by 600
Proteinuria in diabetic kidney disease: A mechanistic viewpoint
Jefferson, J. A., Shankland, S. J., & Pichler, R. H. (2008) · Kidney International · doi:10.1038/ki.2008.128 · Cited by 419
Diagnosis and Management of Type 2 Diabetic Kidney Disease
Doshi, S. M., & Friedman, A. N. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11111016 · Cited by 344
Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes
Molitch, M. E., Adler, A. I., Flyvbjerg, A., Nelson, R. G., So, W.-Y., Wanner, C., Kasiske, B. L., Wheeler, D. C., de Zeeuw, D., & Mogensen, C. E. (2015) · Kidney International · doi:10.1038/ki.2014.128 · Cited by 268
Physiological Regulation of Prostaglandins in the Kidney
Hao, C.-M., & Breyer, M. D. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100614 · Cited by 247
Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway
Zhu, L., Han, J., Yuan, R., Xue, L., & Pang, W. (2018) · Biological Research · doi:10.1186/s40659-018-0157-8 · Cited by 208
Salidroside stimulates the Sirt1/PGC-1α axis and ameliorates diabetic nephropathy in mice
Xue, H., Li, P., Luo, Y., Wu, C., Liu, Y., Qin, X., Huang, X., & Sun, C. (2019) · Phytomedicine · doi:10.1016/j.phymed.2018.10.031 · Cited by 188
Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms
Tonna, S. J., El‐Osta, A., Cooper, M. E., & Tikellis, C. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.55 · Cited by 163
Mechanistic Insight and Management of Diabetic Nephropathy: Recent Progress and Future Perspective
Xue, R., Gui, D., Zheng, L., Zhai, R., Wang, F., & Wang, N. (2017) · Journal of Diabetes Research · doi:10.1155/2017/1839809 · Cited by 160
Self-citationJiang, G., Luk, A. O. Y., Tam, C. H. T., Xie, F., Carstensen, B., Lau, E. S. H., Lim, C. K. P., Lee, H. M., Ng, A. C. W., Ng, M. C. Y., et al. (2019) · Kidney International · doi:10.1016/j.kint.2018.08.026 · Cited by 159
The Life and Death of Protein Kinase C
Gould, C. M., & Newton, A. C. (2008) · Current Drug Targets · doi:10.2174/138945008785132411 · Cited by 153
Sattarinezhad, A., Roozbeh, J., Yeganeh, B. S., Omrani, G. R., & Shams, M. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.05.010 · Cited by 148
SGLT2 Inhibition for the Prevention and Treatment of Diabetic Kidney Disease: A Review
Alicic, R. Z., Johnson, E. J., & Tuttle, K. R. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.03.022 · Cited by 137
Meta-analysis of the clinical value of Astragalus membranaceus in diabetic nephropathy
Li, M., Wang, W., Xue, J., Gu, Y., & Lin, S. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.10.012 · Cited by 135
Li, X.-Y., Wang, S.-S., Han, Z., Han, F., Chang, Y.-P., Yang, Y., Xue, M., Sun, B., & Chen, L.-M. (2017) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2017.08.011 · Cited by 132
Han, W.-B., Ma, Q., Liu, Y., Wu, W., Tu, Y., Huang, L., Long, Y., Wang, W., Yee, H.-Y., Wan, Z.-Y., et al. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.12.021 · Cited by 117
Wang, X., Gao, Y., Tian, N., Wang, T., Shi, Y., Xu, J., & Wu, B. (2019) · Scientific Reports · doi:10.1038/s41598-018-36911-1 · Cited by 117
Review of Herbal Traditional Chinese Medicine for the Treatment of Diabetic Nephropathy
Sun, G., Li, C., Cui, W., Guo, Q.-Y., Dong, C., Zou, H.-B., Liu, S., Dong, W., & Miao, L. (2015) · Journal of Diabetes Research · doi:10.1155/2016/5749857 · Cited by 115
Mechanical Forces in Diabetic Kidney Disease
Gnudi, L., Thomas, S. M., & Viberti, G. C. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006121362 · Cited by 115
Prevention of Diabetic Nephropathy in Rats by Prostaglandin E Receptor EP1-Selective Antagonist
Makino, H., Tanaka, I., Mukoyama, M., Sugawara, A., Mori, K., Muro, S., Suganami, T., Yahata, K., Ishibashi, R., Ohuchida, S., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000019782.37851.bf · Cited by 114
Guo, H., Wang, Y., Zhang, X., Zang, Y., Zhang, Y., Wang, L., Wang, H., Wang, Y., Cao, A., & Peng, W. (2017) · Scientific Reports · doi:10.1038/s41598-017-07061-7 · Cited by 104
Therapeutic usefulness of Keishi-bukuryo-gan for diabetic nephropathy
Nakagawa, T., Yokozawa, T., TERASAWA, K., & Nakanishi, K. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/002235702450 · Cited by 102
Tu, Q., Li, Y., Jin, J., Jiang, X., Ren, Y., & He, Q. (2019) · Pharmaceutical Biology · doi:10.1080/13880209.2019.1688843 · Cited by 102
Wang, Z. S., Xiong, F., Xie, X. H., Chen, D., Pan, J. H., & Li, C. (2015) · BMC Nephrology · doi:10.1186/s12882-015-0031-7 · Cited by 99
SIRT1 Is a Potential Drug Target for Treatment of Diabetic Kidney Disease
Zhong, Y., Lee, K., & He, C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00624 · Cited by 96
Zhang, B., Zhang, X., Zhang, C., Shen, Q., Sun, G., & Sun, X. (2019) · Molecules · doi:10.3390/molecules24020247 · Cited by 95
Self-citationYang, F., Qu, Q., Zhao, C., Liu, X., Yang, P., Li, Z., Han, L., & Shi, X. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110479 · Cited by 94
Mao, Z., Shen, S., Wan, Y., Sun, W., Chen, H.-L., Huang, M., Yang, J., Wu, W., Tang, H., & Tang, R. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.07.036 · Cited by 91
Self-citationLi, P., Chen, Y., Liu, J., Hong, J., Deng, Y., Yang, F., Xiu-ping, J., Gao, J. S., Li, J., Fang, H., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126027 · Cited by 91
Treatment of db/db diabetic mice with triptolide: a novel therapy for diabetic nephropathy
Gao, Q., Shen, W., Qin, W., Zheng, C., Zhang, M., Zeng, C., Wang, L., Wang, J., Zhu, X., & Liu, Z. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq245 · Cited by 89
Zhang, M.-H., Feng, L., Zhu, M., Gu, J., Jiang, J., Cheng, X., Ding, S., Wu, C., & Jia, X. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.11.015 · Cited by 87
Qi, M.-Y., Kai-Chen, Liu, H.-R., Su, Y., & Su-qing, Y. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.10.015 · Cited by 87
Tian, N., Gao, Y., Wang, X., Wu, X., Zou, D., Zhu, Z., Han, Z., Wang, T., & Shi, Y. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s167405 · Cited by 87
Lei, X., Zhang, L., Li, Z., & Ren, J. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s166525 · Cited by 83
Qiu, Y.-Y., Tang, L., & Wei, W. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.01.009 · Cited by 82
Moringa Isothiocyanate Activates Nrf2: Potential Role in Diabetic Nephropathy
Cheng, D., Gao, L., Su, S., Sargsyan, D., Wu, R., Raskin, I., & Kong, A. T. (2019) · The AAPS Journal · doi:10.1208/s12248-019-0301-6 · Cited by 82
Protective Effects of Berberine on Renal Injury in Streptozotocin (STZ)-Induced Diabetic Mice
Zhang, X., He, H., Liang, D., Jiang, Y., Liang, W., Chi, Z., & Ma, J. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081327 · Cited by 80
Puerarin Attenuates Diabetic Nephropathy by Promoting Autophagy in Podocytes
Li, X., Zhu, Q., Zheng, R., Yan, J., Wei, M., Fan, Y., Deng, Y., & Zhong, Y. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00073 · Cited by 79
La, Z., Shergis, J. L., Yang, L., Zhang, A. L., Guo, X., Zhang, L., Zhou, S., Zeng, L., Mao, W., & Xue, C. C. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.111921 · Cited by 77
Therapeutic Considerations for Antihyperglycemic Agents in Diabetic Kidney Disease
Neumiller, J. J., Alicic, R. Z., & Tuttle, K. R. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016121372 · Cited by 75
Wang, J., Huang, H., Liu, P., Tang, F., Jia, Q., Huang, W., Chen, F., Guo, F., Liu, W., & Yang, B. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.08.087 · Cited by 74
Chen, Y., Chen, J., Jiang, M., Fu, Y., Zhu, Y., Jiao, N., Liu, L., Du, Q., Wu, H., Xu, H., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117653 · Cited by 73
Wu, W., Hu, W., Han, W.-B., Liu, Y., Tu, Y., Yang, H., Fang, Q., Zhou, M.-Y., Wan, Z.-Y., Tang, R., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00443 · Cited by 72
Celastrol attenuates renal injury in diabetic rats via MAPK/NF‐κB pathway
Zhang, M., Chen, Y., Yang, M., Fan, X., Xie, H., Zhang, L., Nie, Y., & Yan, M. (2019) · Phytotherapy Research · doi:10.1002/ptr.6314 · Cited by 72
Li, C., Guan, X., Wang, R., Xie, Y., Zhou, H., Ni, W., & Tang, L. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117277 · Cited by 72
La, Z., Yang, L., Shergis, J. L., Zhang, L., Zhang, A. L., Guo, X., Qin, X., Johnson, D. W., Liu, X., Lu, C., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025653 · Cited by 71
Wen, D., Tan, R., Zhao, C.-Y., Li, J., Zhong, X., Diao, H., Lin, X., Duan, D. D., Jun-ming, F., Xie, X., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00732 · Cited by 66
Renoprotective effect of berberine on type 2 diabetic nephropathy in rats
Sun, S., Zhao, T., Zhang, H., Huang, X., Zhang, W., Zhang, L., Yan, M., Dong, X., Wang, H., Wen, Y., et al. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12402 · Cited by 65
Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in Rats
Zhao, T., Sun, S., Zhang, H., Huang, X., Yan, M., Dong, X., Wen, Y., Wang, H., Lan, H. Y., & Li, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147693 · Cited by 63
Skimmin, a coumarin, suppresses the streptozotocin-induced diabetic nephropathy in wistar rats
Zhang, S., Yang, J., Li, H., Li, Y., Liu, Y., Zhang, D., Zhang, F., Zhou, W., & Chen, X. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.05.017 · Cited by 62
Preventive effects of North American ginseng (Panax quinquefolium) on diabetic nephropathy
Sen, S., Chen, S., Feng, B., Wu, Y., Lui, E. M. K., & Chakrabarti, S. (2012) · Phytomedicine · doi:10.1016/j.phymed.2012.01.001 · Cited by 62
Chen, Y., Liu, Q., Shan, Z., Mi, W., Zhao, Y., Li, M., Wang, B., Zheng, X., & Feng, W. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01477 · Cited by 62
Zhang, X., Jiang, C., Liu, Y., Lou, D.-X., Huang, Y., Gao, M. Q., Zhang, J., Yin, Z., & Pan, K. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.153060 · Cited by 61
Chen, J., Hou, X., Wang, G., Zhong, Q.-X., Liu, Y., Qiu, H., Yang, N., Gu, J., Wang, C., Zhang, L., et al. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.09.043 · Cited by 60
Zhao, T., Zhang, H. J., Lü, X., Huang, X. R., Zhang, W. K., Wang, H., Lan, H. Y., & Li, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090807 · Cited by 59
Protective effect of berberine on renal fibrosis caused by diabetic nephropathy
Zhong, L., & Zhang, W. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6707 · Cited by 58
Yang, W., Li, Y., Gao, H., Wu, X., Wang, X., Wang, X., Xiang, L., Ren, D., Lou, H., & Shen, T. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.08.037 · Cited by 58
Hong, J., Li, W.-W., Wang, L., Guo, H., Jiang, Y., Yun-jia, G., Tu, P., & Wang, X. (2017) · Chinese Medicine · doi:10.1186/s13020-017-0134-0 · Cited by 57
Paeoniflorin prevents TLR2/4-mediated inflammation in type 2 diabetic nephropathy
Zhang, T., Zhu, Q., Shao, Y., Wang, K., & Wu, Y. (2017) · BioScience Trends · doi:10.5582/bst.2017.01104 · Cited by 54
Hispidulin alleviates high-glucose-induced podocyte injury by regulating protective autophagy
Wu, F., Li, S., Zhang, N., Huang, W., Li, X., Wang, M., Bai, D., & Han, B. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.017 · Cited by 54
Self-citationJing, D., Bai, H., & Yin, S. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5131 · Cited by 53
Zhang, H., Zhao, T., Gong, Y., Dong, X., Zhang, W., Sun, S., Wang, H., Gu, Y., Lu, X., Yan, M., et al. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.11.020 · Cited by 50
de Zeeuw, D., Renfurm, R. W., Bakris, G. L., Rossing, P. R., Perkovic, V., Hou, F. F., Nangaku, M., Sharma, K., Heerspink, H. J. L., García-Hernández, A., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30289-4 · Cited by 50
MicroRNA-410-5p exacerbates high-fat diet-induced cardiac remodeling in mice in an endocrine fashion
Zou, T., Zhu, M. J., Ma, Y., Xiao, F., Yu, X. M., Li, X., Ma, L., Yang, J., & Dong, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-26646-4 · Cited by 49
Seo, E., Kang, H., Oh, Y. S., & Jun, H. (2017) · Nutrients · doi:10.3390/nu9080828 · Cited by 47
Liu, H., Tang, X., Dai, D., & Dai, Y. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.05.015 · Cited by 46
Liu, M., Pan, Q., Chen, Y., Yang, X., Zhao, B., Jia, L., Zhu, Y., Zhang, B., Gao, X., Li, X., et al. (2015) · Scientific Reports · doi:10.1038/srep11219 · Cited by 46
Zhang, M., Liu, M., Xiong, M., Gong, J., & Tan, X. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.02.007 · Cited by 45
Shao, Y., Xu, X., Wang, K., Qi, X., & Wu, Y. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s149504 · Cited by 42
Wu, X., Gao, Y., Xu, L., Zou, D., Zhu, Z., Wang, X., Yao, W., Luo, L., Tong, Y., Tian, N., et al. (2017) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x17500586 · Cited by 40
Yang, S., Deng, H., Zhang, Q., Xie, J., Zeng, H., Jin, X., Ling, Z., Shan, Q., Liu, M., Ma, Y., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151857 · Cited by 38
Fang, D., Wan, X., Deng, W., Guan, H., Ke, W., Xiao, H., & Li, Y. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.680 · Cited by 35
Xiao, Y., Liu, Y., Keqiang, Y., Zhou, L., Bi, J., Cheng, J., Li, F., Luo, R., & Zhao, X. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/937549 · Cited by 34
Ni, W., Tang, L., Zhou, H., Ding, H., & Qiu, Y.-Y. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12837 · Cited by 34
Xiang, L., Jiang, P., Zhou, L., Sun, X., Bi, J., Cui, L., Nie, X., Luo, R., Zhao, X., & Liu, Y. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/1064924 · Cited by 34
Liu, X., Yao, L., Sun, D., Zhu, X., Liu, Q., Xu, T., & Wang, L. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3483 · Cited by 33
Zhai, R., Jian, G., Chen, T., Xie, L., Xue, R., Gao, C., Wang, N., Xu, Y., & Gui, D. (2019) · Journal of Diabetes Research · doi:10.1155/2019/1602892 · Cited by 33
Self-citationXiong, C., Li, L., Wang, B., Chen, H., XiaoWei, L., Hongbao, L., & Zhang, P. (2019) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2019.11.001 · Cited by 33
Self-citationLin, L., Wang, Q., Yi, Y., Wang, S., & Qiu, Z. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/1509063 · Cited by 32
Cui, F.-Q., Tang, L., Gao, Y., Wang, Y.-F., Yuan, M., Shen, C., Shen, Z., Liu, Z., Zhao, W., & Liu, W. J. (2019) · Journal of Diabetes Research · doi:10.1155/2019/2981705 · Cited by 31
Ankita, P., Deepti, B., & Mhetre, N. K. (2014) · Pharmaceutical Biology · doi:10.3109/13880209.2014.910533 · Cited by 30
Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes
Katavetin, P., & Katavetin, P. (2009) · New England Journal of Medicine · doi:10.1056/nejmc091561 · Cited by 29
Lü, Q., Li, C., Chen, W., Shi, Z., Zhan, R., & He, R. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/6806943 · Cited by 29
Wang, Y., Shi, L., Wang, L.-Y., Xu, J., & Feng, Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160922473 · Cited by 28
Self-citationChen, Y., Gong, Z., Cai, G., Gao, Q., Chen, X., Li, T., Wei, R., & Zhou, J. (2014) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-014-1891-6 · Cited by 28
Podoplanin mediates the renoprotective effect of berberine on diabetic kidney disease in mice
Yu, J., Zong, G.-N., Wu, H., & Zhang, K.-Q. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0263-3 · Cited by 27
QiDiTangShen Granules Activate Renal Nutrient-Sensing Associated Autophagy in db/db Mice
Wang, X., Zhao, L. D., Ajay, A. K., Jiao, B., Zhang, X., Wang, C., Gao, X. J., Yuan, Z., Liu, H., & Liu, W. J. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01224 · Cited by 27
NaoXinTong Capsules inhibit the development of diabetic nephropathy in db/db mice
Yang, S., Liu, M., Chen, Y., Ma, C., Liu, L., Zhao, B., Wang, Y., Li, X., Zhu, Y., Gao, X., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26746-1 · Cited by 26
Berberine regulates the expression of E-prostanoid receptors in diabetic rats with nephropathy
Tang, L. Q., Liu, S., Zhang, S. T., Zhu, L. N., & Wang, F. L. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3196-4 · Cited by 25
Effects of Zishentongluo in Patients with Early-Stage Diabetic Nephropathy
Ma, J.-W., Xu, L., Dong, J., Wei, H., Zhi, Y., Ma, X., & Zhang, W. (2013) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x13500249 · Cited by 23
Chen, X., Wang, H., Jiang, M., Zhao, J., Fan, C., Wang, Y., & Peng, W. (2018) · Europe PMC (PubMed Central) · Cited by 23
Liu, J.-Y., Chen, X., Tang, S. C. W., Lao, L., Sze, S. C. W., Lee, C., & Zhang, K. Y. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.01.034 · Cited by 22
Diabetic Nephropathy: Causes and Managements
Tripathi, Y. B., & Yadav, D. (2012) · Recent Patents on Endocrine Metabolic & Immune Drug Discovery · doi:10.2174/1872214811307010057 · Cited by 22
Song, H.-X., Gong, J., & Chen, W. (2005) · PubMed · Cited by 22
Yuanlin, P., & Dehai, Y. (2018) · 中医杂志:英文版 · doi:10.1016/s0254-6272(18)30921-x · Cited by 22
Lu, J., Peng, J., Xiang, M., He, L., Wang, D., Xiong, G., & Li, S. (2018) · Bioscience Reports · doi:10.1042/bsr20180071 · Cited by 20
Self-citationLi, Z., Deng, W., Cao, A., Zang, Y., Wang, Y., Wang, H., Wang, L., & Peng, W. (2019) · PubMed · Cited by 18
Chen, Y., Liu, Z., Zhou, F., Zhao, H., Yang, Q., Li, H., Sun, J., & Wang, S. (2016) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2015.191 · Cited by 17
Voroneanu, L. E., Siriopol, D. C., Dumea, R., Bădărau, S., Kanbay, M., Afşar, B., Gavrilovici, C., & Covic, A. C. (2017) · International Urology and Nephrology · doi:10.1007/s11255-017-1697-5 · Cited by 16
Cao, X., Wei, R., Zhou, J. F., Zhang, X., Gong, W., Jin, T., & Chen, X. (2019) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-019-2598-1 · Cited by 16
Zhang, N., Gao, Y., Zou, D., Wang, J., Li, J.-Y., Zhou, S., Zhu, Z., Zhao, X., Xu, L., & Zhang, H. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/123497 · Cited by 15
Attenuating Effects of Wen-Pi-Tang Treatment in Rats with Diabetic Nephropathy
Yokozawa, T., Satoh, A., Nakagawa, T., & Yamabe, N. (2006) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x06003850 · Cited by 15
Wang, X., Xu, Y., Chu, C.-L., Li, H., Mi, J. D., Wen, Z., Zhang, S., Wang, Q., & Quan, S. (2019) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2018-0425 · Cited by 15
An, X., Zhang, M., Zhou, S., Lu, T., Chen, Y., & Yao, L. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01195 · Cited by 13
Zhao, J., Mo, C., Meng, L., Liang, C.-Q., Cao, X., & Shi, W. (2019) · PubMed · doi:10.19540/j.cnki.cjcmm.20190109.001 · Cited by 10
Jiang, J., Yin, J., Liu, X., Wang, H., & Lu, G. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/1741924 · Cited by 9
Wang, F., Wang, Y., Lin, H., et al. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/4276052 · Cited by 8
Cited by
The sirtuin family in health and disease
Wu, Q.-J., Zhang, T.-N., Chen, H.-H., Yu, X.-F., Lv, J.-L., Liu, Y.-Y., Liu, Y.-S., Zheng, G., Zhao, J.-Q., Wei, Y.-F., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01257-8 · Cited by 862
Self-citation
Metadata
- Authors
- Tang, G., Li, S., Zhang, C., Chen, H., Wang, N., & Feng, Y.
- Venue
- Acta Pharmaceutica Sinica B
- Publisher
- Elsevier BV
- Published
- 2021-09
- Volume
- 11
- Issue
- 9
- Pages
- 2749-2767
- ISSN
- 2211-3835 (ISSN-L)
- OpenAlex
- W3127843453
- Cited by
- 364
- References
- 111
- FWCI
- 29.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.